New cheek wrinkle treatment under study

NCT ID NCT07145905

Ongoing Symptom relief Sponsor: Teoxane SA Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a treatment called TCRM, injected into the cheeks to reduce fine lines. About 130 healthy adults are taking part. The goal is to see if the treatment improves the look of the cheeks 4 weeks after the last injection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TCRM (a device-based injectable treatment for wrinkles)
What this could lead to: If it works, this could offer a new option for reducing fine lines on the cheeks.
What could go wrong: This is an early-stage study without a placebo group, so results may not prove effectiveness. Side effects from injections are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEEK WRINKLES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHEEK WRINKLES SKIN AGING

Contacts and locations

Locations

Centro Médico Lajo Rosso

Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.